A sulfur-containing nucleoside antibiotic from Photorhabdus
mBio · 2025
DOI: 10.1128/mbio.02164-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift mBio, 2025. Verfasst von Sangkeun Son und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Antimicrobial Discovery Center, Northeastern University, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Photorhabdus, Thymidine, Nucleosides. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
We report the discovery of 4′-thiothymidine (4′sT), a sulfur-containing nucleoside antibiotic produced by the nematode symbiont Photorhabdus asymbiotica . 4′sT exhibits antibacterial activity against Escherichia coli , Stenotrophomonas maltophilia , and Klebsiella pneumoniae . The production of 4′sT was increased in rifampicin-resistant mutants. Heterologous expression of the radical SAM enzyme-containing gene cluster confirmed its biosynthetic origin. Resistant mutants mapped to tdk, which encodes thymidine kinase in the thymidine salvage pathway. Mechanistic studies revealed that 4′sT is a prodrug activated via the thymidine salvage pathway and incorporated into DNA, where it inhibits replication and triggers the SOS response. Clinical E. coli isolates were resistant, but inhibition of de novo thymidylate synthesis with trimethoprim rendered them highly susceptible, indicating that strain-selective activity is governed by differences in thymidine metabolism. These findings highlight the role of metabolic context in determining antibiotic selectivity and demonstrate the utility of rifampicin resistance for assessing silent biosynthetic gene clusters to discover new antimicrobial compounds. IMPORTANCE Introducing novel antibiotics is essential to counter the spread of drug-resistant pathogens. Here, we report the discovery of 4′-thiothymidine (4′sT), a nucleoside antibiotic from the nematode symbiont Photorhabdus asymbiotica , identified through activation of a silent biosynthetic gene cluster. 4′sT features an unusual 4′-thiosugar moiety. We identified its biosynthetic gene cluster, including a radical SAM enzyme presumably involved in sulfur incorporation. 4′sT exhibits strain-selective activity that is governed by differences in thymidine metabolism rather than variations in the molecular target. These findings expand our knowledge of antibiotics with unusual selective activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology, Antimicrobial Discovery Center, Northeastern University, Boston, Massachusetts, USA.
ORCID-Profile: Sangkeun Son, Kim Lewis
Förderung
- NIAID NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Son, S., Shahsavari, N., Privalsky, T., Hawkins, B. A., Lee, M. H., Pitt, N., Iinishi, A., Taher, R., Gupta, N., Shankar, C. S., Patel, J., & Lewis, K. (2025). A sulfur-containing nucleoside antibiotic from Photorhabdus. mBio. https://doi.org/10.1128/mbio.02164-25
Vancouver
Son S, Shahsavari N, Privalsky T, Hawkins BA, Lee MH, Pitt N, et al. A sulfur-containing nucleoside antibiotic from Photorhabdus. mBio. 2025. doi:10.1128/mbio.02164-25
BibTeX
@article{Son2025,
author = {Son, Sangkeun and Shahsavari, Negar and Privalsky, Thomas and Hawkins, Bryson A and Lee, Mi-Hyun and Pitt, Norman and Iinishi, Akira and Taher, Raleb and Gupta, Nikita and Shankar, Chandra Sekar and Patel, Jaini and Lewis, Kim},
title = {A sulfur-containing nucleoside antibiotic from Photorhabdus},
journal = {mBio},
year = {2025},
doi = {10.1128/mbio.02164-25}
}
EUVIMED